INDIGO Home University of Illinois at Urbana-Champaign logo uic building uic pavilion uic student center

Molecular Mechanisms and Experimental Therapies of Pain in Multiple Sclerosis

Show full item record

Bookmark or cite this item: http://hdl.handle.net/10027/21777

Files in this item

File Description Format
PDF HU-DISSERTATION-2017.pdf (3MB) Restricted Access (no description provided) PDF
Title: Molecular Mechanisms and Experimental Therapies of Pain in Multiple Sclerosis
Author(s): Hu, Xiaoyu
Advisor(s): Wang, Zaijie Jim
Contributor(s): Brodie, Mark S; Molokie, Robert E; Park, Thomas; Schlemmer, Francis; Wang, Zaijie Jim
Department / Program: Biopharmaceutical Sciences
Degree Granting Institution: University of Illinois at Chicago
Degree: PhD, Doctor of Philosophy
Genre: Doctoral
Subject(s): pain multiple sclerosis CaMKII curcumin
Abstract: Multiple sclerosis is an autoimmune disorder in central nervous system with manifestations of neuroinflammation and demyelination. Pain associated with multiple sclerosis is a common and severe symptom, but is barely studied in the pharmacological and medicinal researches compared with the motor dysfunction of this disease. In this study, we focused on investigating the molecular and cellular mechanisms underlying multiple sclerosis associated pain, and also on exploring the potential therapeutic interventions. To study the pain behavior of multiple sclerosis, an animal model of EAE, widely used for pathology study of multiple sclerosis, has been established and evaluated to present evoked mechanical and thermal hyperalgesia and non-evoked ongoing pain in mice. We discovered that inhibition of spinal CaMKIIα, a multifunctional serine/threonine kinase, is able to attenuate the pain in EAE mice. A role of IL-17, an immune factor, in initiating the EAE pain and regulating CaMKIIα was also identified. Specific targeting CaMKIIα in dorsal horn of spinal cord can be a potential therapy for multiple sclerosis associated pain. Curcumin was also studied as a potential therapeutics for pain. A novel nanoformulation has been employed to improve the solubility and bioavailability of curcumin, which is the main problem that hindered the medical use of curcumin for years. A dose-dependent effect of curcumin in attenuating opioid tolerance and dependence, and opioid-induced hyperalgesia was observed in this study, and this behavior observation was consistently linked to the pharmacological inhibition of CaMKIIα in brain and spinal dorsal horn. These findings provide better insights into the pharmacological mechanisms underlying the multiple sclerosis associated pain, and offered promising targeted experimental therapies for future development of effective treatment for pain management in multiple sclerosis.
Issue Date: 2017-03-17
Type: Thesis
URI: http://hdl.handle.net/10027/21777
Date Available in INDIGO: 2017-10-27
Date Deposited: May 2017
 

This item appears in the following Collection(s)

Show full item record

Statistics

Country Code Views
China 14
United States of America 10
Ukraine 6
Russian Federation 5
Switzerland 2

Browse

My Account

Information

Access Key